Attention Deficit Hyperactivity DisorderNCT05070481
Prevalence of Disruptive Behavior in Children With Attention Deficit Hyperactivity Disorder(ADHD)
An observational study of Attention Deficit Hyperactivity Disorder, run by Eman Sayed Hassan Mahros.
Trial summary
Identification of prevalence and Risk factors for disruptive behavior in children with Attention Deficit Hyperactivity Disorder and Early recognition of disruptive behavior in children with ADHD Read more about this study
- Who is it for?
- Ages 6 months to 1 year
- Conditions the study is for
- Attention Deficit Hyperactivity Disorder
- How many people
- 3 participants
- Where
- No sites listed yet
- Study dates
- Oct 2021to Oct 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 months to 1 year
- All sexes
- No healthy volunteers
- Child
Study population: Patient with ADHD that meet the selection criteria in the period from October 2021 till June 2022
Who may be able to join
- All children under 18 years old with ADHD at Neuro pyshictric outpatient clinic
Who cannot join
- Any psychiatric problems other than ADHD like :Autism, depression, schizophrenia or mental retardation
About this study
Official title: Clinical Observational and Statistical Study for Detection of Prevalence and Risk Factors of Disruptive Behavior in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Identification of prevalence and Risk factors for disruptive behavior in children with Attention Deficit Hyperactivity Disorder and Early recognition of disruptive behavior in children with ADHD
Read the detailed description
ADHD is asustaible pattern of inattention Hyperactivity and lmpulsive behavior which can have harmful consequences for the patients social life it was called childhood hyperkinetic reaction before it is estimated that 3 to 5 percent of children show symptoms in primary school in addition to the role of genetic factor in the incidence of this mental disorder ,family imbalance and other anxiety factors play arole in the continuity of disorder.disruptive behavior with a prevalence of 1 to 10percent is a prevalent disorder in primary school similar to ADHD it is 4 to 12 times more frequent among boys compared with girls . disruptive behavior characterized by aggression and violating others rights . This study is screening survey questionnaire study will be done in Assuit University children hospital Neuro psychiatric outpatient clinic in all children under 18 years old have ADHD and exclude other psychiatric problems as :Autism , depression , Schizophrenia or mental retardation . investigator will take full history : personal history : name , date of birth ,age,sex ,age of onset of ADHD ,type of ADHD,severity of ADHD ,type of disruptive behavior , history of treatment,Family history : sibling have ADHD,smoking of parents,drug use parents,social problems: divorce or death of parents . Investigator will use DSM V criteria as adignostic criteria and screening data evaluated by ADHD symptoms check list -4 (ADHD -sc4 scale scores) : symptoms count scores and symptoms severity scores . All for detect outcome of the patient with ADHD .
- Conditions
- Attention Deficit Hyperactivity Disorder
- Medical subject headings
- Attention Deficit Disorder with Hyperactivity
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of prevalence of disruptive behavior in children with ADHD by Sc -4 scale and DSM V score
Screening data by ADHD symptoms chick list -4 rating scale(ADHD Sc-4 scale ) to detect symptoms count score and also invistigator use Diagnostic and Statistical Manual of mental disorders fifth edition(DSM V score) to assess the severity of symptoms
Measured: Primarily from October 2021 till June 2022
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Oct 2021
- Study startOct 2021 (estimated)
- Primary completionJun 2022 (estimated)
- Study completionOct 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Attention Deficit Hyperactivity DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 3 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Eman Sayed Hassan Mahros
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Eman Sayed Hassan Mahros, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05070481
- Sponsor's protocol ID
- 271087
- Status last verified
- Sep 2021
- First submitted
- 18 Sep 2021
- Last updated
- 7 Oct 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Austerman J. ADHD and behavioral disorders: Assessment, management, and an update from DSM-5. Cleve Clin J Med. 2015 Nov;82(11 Suppl 1):S2-7. doi: 10.3949/ccjm.82.s1.01.
PubMed 26555810
Study at a glance
From the registry record, last updated by the sponsor on 7 Oct 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Observational and Statistical Study for Detection of Prevalence and Risk Factors of Disruptive Behavior in Children With Attention Deficit Hyperactivity Disorder (ADHD)
- ClinicalTrials.gov ID
- NCT05070481
- Acronym / sponsor ID
- 271087
- Conditions
- Attention Deficit Hyperactivity Disorder
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 3 participants (estimated)
- Lead sponsor
- Eman Sayed Hassan MahrosUniversity, hospital or other
- Study start
- Oct 2021 (estimated)
- Primary completion
- Jun 2022 (estimated)
- Study completion
- Oct 2022 (estimated)
- First posted
- 7 Oct 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Identification of prevalence and Risk factors for disruptive behavior in children with Attention Deficit Hyperactivity Disorder and Early recognition of disruptive behavior in children with ADHD
Detailed description
ADHD is asustaible pattern of inattention Hyperactivity and lmpulsive behavior which can have harmful consequences for the patients social life it was called childhood hyperkinetic reaction before it is estimated that 3 to 5 percent of children show symptoms in primary school in addition to the role of genetic factor in the incidence of this mental disorder ,family imbalance and other anxiety factors play arole in the continuity of disorder.disruptive behavior with a prevalence of 1 to 10percent is a prevalent disorder in primary school similar to ADHD it is 4 to 12 times more frequent among boys compared with girls . disruptive behavior characterized by aggression and violating others rights . This study is screening survey questionnaire study will be done in Assuit University children hospital Neuro psychiatric outpatient clinic in all children under 18 years old have ADHD and exclude other psychiatric problems as :Autism , depression , Schizophrenia or mental retardation . investigator will take full history : personal history : name , date of birth ,age,sex ,age of onset of ADHD ,type of ADHD,severity of ADHD ,type of disruptive behavior , history of treatment,Family history : sibling have ADHD,smoking of parents,drug use parents,social problems: divorce or death of parents . Investigator will use DSM V criteria as adignostic criteria and screening data evaluated by ADHD symptoms check list -4 (ADHD -sc4 scale scores) : symptoms count scores and symptoms severity scores . All for detect outcome of the patient with ADHD .
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 6 months to 1 year
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Patient with ADHD that meet the selection criteria in the period from October 2021 till June 2022
Key inclusion criteria (1 listed)
- All children under 18 years old with ADHD at Neuro pyshictric outpatient clinic
Key exclusion criteria (1 listed)
- Any psychiatric problems other than ADHD like :Autism, depression, schizophrenia or mental retardation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Assessment of prevalence of disruptive behavior in children with ADHD by Sc -4 scale and DSM V score
Time frame: Primarily from October 2021 till June 2022
Screening data by ADHD symptoms chick list -4 rating scale(ADHD Sc-4 scale ) to detect symptoms count score and also invistigator use Diagnostic and Statistical Manual of mental disorders fifth edition(DSM V score) to assess the severity of symptoms
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Oct 2021.
- Results publication: PubMed 26555810Austerman J. ADHD and behavioral disorders: Assessment, management, and an update from DSM-5. Cleve Clin J Med. 2015 Nov;82(11 Suppl 1):S2-7. doi: 10.3949/ccjm.82.s1.01.
- Individual participant dataSharing planned: No
Related trials for Attention Deficit Hyperactivity Disorder
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingObservational study
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Disruptive Behavior Disorders, Conduct Disorder
Recruiting
Micronutrient Supplementation and Chronotherapy in Children With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
RecruitingPhase 3
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Attention Deficit Hyperactivity Disorder, run by Eman Sayed Hassan Mahros.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of prevalence of disruptive behavior in children with ADHD by Sc -4 scale and DSM V score (time frame: Primarily from October 2021 till June 2022). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05070481, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2021.